Antibiotics

#Antibiotics #CAR-T #Digital twin

This week in drug discovery (6-10 June) 

News round-up by DDW’s Reece Armstrong for 6-10 June Antibiotic developments, vaccines for MMR and business expansions are some of the features of this week’s news round-up. US gets another MMR vaccine option in GSK’s Priorix   GSK’s vaccine for the prevention of measles, mumps and rubella (MMR) has been… Read More

#News

Antibiotics
#Antibiotics #Antimicrobial resistance (AMR) #Preclinical development

Nosopharm brings antibiotic one step closer to clinical development

Biotechnology company Nosopharm has reported positive toxicology results for its first-in-class antibiotic for the treatment of multidrug-resistant hospital-acquired infections. The company’s NOSO-502 is the first clinical candidate in the new class of antibiotics called Odilorhabdins and is being developed alongside GNA NOW, a European Consortium funded by the Innovative Medicines… Read More

#News

#Antibiotics #Drug development #Funding #Research

US researcher awarded $3.6 million to study antibiotic resistance

Sanford Burnham Prebys professor Andrei Osterman, Ph.D., has been awarded a $3.6 million grant from the National Institutes of Health (NIH) to expand current knowledge of antibiotic resistance, which will inform more precise antibiotic prescribing practices and help researchers develop drugs that are harder for bacteria to resist.   Context… Read More

#News

#Antibiotics #Funding

ANTRUK spends largest ever sum on antibiotic research projects 

Antibiotic Research UK (ANTRUK) is funding seven new antibiotic research projects totalling £200,000, reportedly the largest sum it has ever awarded through its 2021 Small Research Grants / Career Development Awards scheme. The grants will fund essential academic research in both basic and applied sciences to help prevent another global pandemic,… Read More

#News

#Antibiotics #Antimicrobials #Collaboration

AMR Action Fund appointment will help with antibiotic development 

 The AMR Action Fund, a public-private partnership supporting the development of new antibiotics to address rising antimicrobial resistance (AMR), has appointed William (Bill) Burns as Board Chair.   Burns has worked in the pharmaceutical and life sciences industry throughout his life, providing invaluable experience for his role as… Read More

#News

#3D modelling #Antibiotics #Biotechnology #Cell / tissue culture #Data #Drug discovery #Drug targets #Drug technology #Imaging

How imaging techniques are innovating drug discovery

Lu Rahman takes look at some of the latest imaging innovation available and how it can benefit drug target identification and drug discovery research. Imaging is an important element within the drug discovery and development process providing researchers with information that can help identify potential drug targets or see how… Read More

#Exclusive Content #News #Trends & Analysis

#Antibiotics #Biomedical research #Drug discovery #Research

ANTRUK launches research grants programme for antibiotic resistance

Antibiotic Research UK (ANTRUK), a charity tackling bacterial antibiotic resistance, has launched its 2021 Small Research Grants / Career Development Awards scheme. This is the charity’s largest grants programme to date. The charity will be awarding one grant of up to £50,000 and six grants of up to £25,000 each. Read More

#News

#Antibiotics #Microbiome

Children who take antibiotics under 2 at risk of health conditions, says research

Children under age two  who take antibiotics are at greater risk for childhood-onset asthma, respiratory allergies, eczema, coeliac disease, obesity and attention deficit hyperactivity disorder, according to a paper written jointly by Mayo Clinic and Rutgers researchers. In a study published in the journal Mayo Clinic Proceedings, the… Read More

#News

#AMR #Antibiotics #Laboratory of the Future

Analytica virtual conference: new approaches in the fight against antibiotic resistance

The Analytica conference accompanies Analytica 2020, which is currently taking place virtually until 23 October. Key topics in focus at the event are  antibiotic resistance and the ‘laboratory of the future’. The number of microbes that are resistant to certain classes of antibiotics is increasing – hampering therapy. Humans and… Read More

#News